...
首页> 外文期刊>Neuroepidemiology >Mortality and cause of death in multiple sclerosis: Findings from a prospective population-based cohort in bizkaia, basque country, Spain
【24h】

Mortality and cause of death in multiple sclerosis: Findings from a prospective population-based cohort in bizkaia, basque country, Spain

机译:多发性硬化症的死亡率和死亡原因:西班牙巴斯克省比斯开亚的前瞻性人群研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Mortality studies of multiple sclerosis (MS) patients are scarce. Objective: To assess mortality of MS patients included in a large MS cohort from the county of Bizkaia in Spain. Methods: Patients were collected from a dynamic population-based cohort of patients with MS from the county of Bizkaia (named the 'Bizkaia cohort') in the Basque Country (Spain). Data from official registries were used for estimating mortality indicators. Results: During a 24-year period (1987-2011), a total of 1,283 patients were included in the Bizkaia cohort. Eighty-nine patients (6.9%) had died before December 31, 2011. The standardized mortality ratio was 2.78 for the whole group (3.26 for men and 2.73 for women), with a decreased life expectancy of 6.53 years. The mean survival from the onset of MS in deceased patients was 22.4 years. Death was related directly or indirectly to MS in 57 patients and unrelated in 27, while the cause of death was unknown in the remaining 5. Respiratory infection and sepsis were the most frequent MS-related causes of death. Differences in survival according to gender or disease course were not observed. Conclusion: Patients with MS included in the 'Bizkaia cohort' had an almost threefold increase in the risk for death. Life expectancy is reduced by 6-10 years.
机译:背景:多发性硬化症(MS)患者的死亡率研究很少。目的:评估来自西班牙比斯开亚县的大型MS队列中的MS患者的死亡率。方法:从西班牙巴斯克县Bizkaia县(称为“ Bizkaia队列”)的动态MS患者队列中收集患者。官方登记处的数据用于估计死亡率指标。结果:在24年期间(1987年至2011年),Bizkaia队列共纳入1,283例患者。 2011年12月31日之前有89名患者(6.9%)死亡。整个组的标准死亡率为2.78(男性为3.26,女性为2.73),预期寿命缩短了6.53年。死者从MS发作起的平均生存时间为22.4年。死亡与MS直接或间接相关,其中57例与27例无关,其余5例中死亡原因未知。呼吸道感染和败血症是与MS相关的最常见死亡原因。没有观察到根据性别或疾病进程的生存差异。结论:“ Bizkaia队列”中的MS患者死亡风险几乎增加了三倍。预期寿命减少6-10年。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号